Dr Haumschild leads a discussion highlighting goals of therapy and social determinants of health affecting MDR HIV diagnosis and treatment. Ryan Haumschild, PharmD, MS, MBA: Mr Driffin, a question ...
The panel discusses considerations for payers as well as patient adherence to treatment in MDR HIV. Ryan Haumschild, PharmD, MS, MBA: At this time, I would like to transition to Mr Driffin. I’d like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results